DXCM  valuation analysis

Name: DexCom Inc
Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. (more)
Industry: Medical Devices
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Oct 28, 2021
Market cap: $57.57B (142nd)
Sales(TTM): $2.32B (717th)
Earnings(TTM): $529.30M (460th)

FFER: 2.42 (why)
Actual price: $572.79
FFEThis is DexCom Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $236.55
Quantile: DXCM is very expensive given its fundamentals.
Prices as of EOD 2021-12-22
Price & Estimates
Sales & Earnings history (TTM)
  • DexCom Inc's sales grew by 27.4% ($1.82B to $2.32B) over one year against a market average growth of 16.3%.
Earnings / MarketCap
DexCom Inc
"Medical Devices" industry
Sales / MarketCap
DexCom Inc
"Medical Devices" industry
Book / MarketCap
DexCom Inc
"Medical Devices" industry
Equity / Assets
DexCom Inc
"Medical Devices" industry